CDX Models

Service Pages

Questions?

Home 5 Service 5 CDX Models

Subcutaneous
Disease# of ModelsModels
Bladder Cancer4RT112; HT-1376; RT112 84; UM-UC-3 
Breast Cancer14MDA-MB-231(x);MDA-MB-468(x2); MDA-MB-436; DU4475; HCC70; MX-1(TNBC total 6);MCF-7(x); ZR-75-1;BT-474(x); T-47D(x); HCC1569; HCC1954; MCF-7-Her2(x); BT-474EEI
Cervical Adenocarcinoma1Hela
Colorectal Cancer12HCT-116; SW620; HT-29; SW480; DLD-1; COLO 205; NCI-H716; RKO; SW948; Colo320DM; LOVO; KM12-Luc
Endometrium Adenocarcinoma2AN3CA; MFE-296
Epidermoid Carcinoma2A431; CAL-27
Epithelioid Sarcoma1VA-ES-BJ  
Esophageal Cancer1T.T                   
Fibrosarcoma1HT-1080
Gastric Cancer8HGC-27(x); MKN-45; AGS; NCI-N87; SNU-16; OCUM-1; SNU-5; MKN-1
Glioblastoma7U87MG; U87MG (nude Rat); U87MG-EGFR VIII, LN229; U251; AM-38; AM-38-Luc
Hypopharyngeal1FaDu
Kidney Cancer 6Caki-1; A-498; 786-O; G-401; ACHN; OS-RC-2
Leukemia22K562; HL-60; MV-4-11; MOLT-4; Kasumi-1; KU812; THP-1; TF-1; HEL 92.1.7; SKM-1; NOMO-1; ARH-77; Kopn-8; MOLM-13; KG-1; OCI-AML-2 (nude Rat); OCI-AML-3 (nude Rat); OCI-AML-2; OCI-AML-3; RS4;11; EOL-1; SKNO-1
Liver Cancer 6Hep 3B2.1-7; SK-HEP-1; HuH-7; Hep3B-OS8-Hpdl1a2; HepG2; JHH-7
Lung Cancer 65NCI-H446; NCI-H2171; NCI-H841; SHP-77; DMS 53; NCI-H69;NCI-H209; NCI-H524; NCI-H1048; NCI-H1930; DMS 79; NCI-H2081; NCI-H1092; NCI-H146; DMS 153; NCI-H2029; NCI-H1417; NCI-H510A; NCI-H526 (SCLC-total 19)NCI-H1568; NCI-H1155; NCI-H2122; NCI-H522; NCI-H1975; NCI-H838; NCI-H358; NCI-H1299; PC-9; NCI-H2228;NCI-H1770;NCI-H2030;NCI-H1993;NCI-H1703; NCI-H647; HCC15; NCI-H1693; NCI-H2106; COR-L105; A549; NCI-H460;NCI-H292 ; NCI-H2009; Calu-3; Calu-6; NCI-H441; NCI-H727; HCC827; NCI-H661; ChaGo-K-1; NCI-H1650; NCI-H596;NCI-H1395;A-427; EBC-1; GCT;NCI-H226; NCI-H1373; RERF-LC-AI; SW 1573; HCC4006, LXF-289; HARA; SK-MES-1; LK2; ABC-1 (NSCLC total 46)
Lymphoma22NAMALWA; Daudi; Raji; Mino; DB; Toledo; SU-DHL-6; MC116;  OCI-Ly19; 
WSU-DLCL2; Z-138; REC-1; Granta-519; RPMI 6666; Pfeiffer(x); Maver-1; Farage; SUDHL-5(x); JeKo-1; DoHH2; JVM-2; BJAB
Medullary Thyroid1TT
Medulloblastoma1Daoy
Melanoma5A375; A2058; C32; IGR-1;WN266-4
Mesothelioma4TO211H; NCI-H28; NCI-H226; ACC-MESO-1(x) 
Myeloma8RPMI 8226; MM.1S; NCI-H929; U266B1; OPM-2; LP-1; HuNS1; MM.1R
Nasopharyngeal1CNE
Neuroblastoma 5BE(2)-C; SH-SY5Y; SK-N-DZ; CHP-212; KELLY
Osteosarcoma3143B; SJSA-1; SK-ES-1         
Ovarian Cancer 10OVCAR-3; A2780; A2780 (nude Rat); Caov-3; SKOV-3; OVIES; TOV21G; OVK18; COV434; TOV112D
Pancreatic Cancer10MIA PaCa-2; Capan-1; PANC-1; AsPC-1; CFPAC-1; BxPC-3; KP4; Panc.08.13; HPAF-II; Panc.03.27
Prostate Cancer5PC-3; LNCaP(x1,x2); DU145; 22RV1; MDA-PCA-2B(+M)
Rhabdomyosarcoma2G-401; SJRH30

Orthotopic
Disease# of ModelsModels
Breast Cancer4MDA-MB-468; MDA-MB-231;xMDA-MB-468-luc; xMDA-MB-231-Luc
Colorectal Cancer1HCT116-luc
Glioblastoma4U87MG; U87 MG-EGFRvIII-Luc; U87MG-Luc; U251-Luc
Human Multiple Myeloma1RPMI8226
Liver Cancer2Hep3B-Luc ; SK-Hep-1-luc
Lung Cancer1NCI-H1299-luc
Ovarian Cancer2OVCAR-3, SKOV-3-Luc
Prostate Cancer2PC-3-luc; x1LNCap-luc

Systemic-Survival
Disease# of ModelsModels
Leukemia10K562;KU812;MV-4-11;HEL 92.1.7; XHP-1;HL-60; MOLM-13, RS4;11; MV-4-11-Luc; OCI-AML3-Luc2
Liver Cancer1HepG2-Luc 
Lymphoma4NAMALWA; Daudi; Raji; Raji-luc
Myeloma2LP-1; KMS34
Neuroblastoma1BE(2)-C 

Metastatic
Disease# of ModelsModels
Breast Cancer2xBT-474-Luc (via brain, carotid artery)
Colon1HCT-116-Luc(by orthotopic)
Glioblastoma1U-87 MG-Luc (via postate)
Lung Cancer6NCI-H1299-Luc (via brain); PC-9-luc (via brain); NCI-H358-Luc2 (via brain); NCI-H1975-Luc (via brain); NCI-H1975-Luc (via intracarotid); PC-9-Luc (via intracarotid)
Melanoma3A-375 (via brain); A375- luc (via intracardiac, brain)
Ovarian Cancer2SK-OV-3-Luc(by orthotopic);  SK-OV-3-Luc (via ascitic)
Prostate Cancer2PC-3-Luc (via intracardia, by orthotopic)

Headquarters

1F & 3F, Block A
2829 JinKe Road
Zhangjiang Hi-Tech Park
PuDong New Area
Shanghai China, 201203

w

Contact Us

China: +86 21 5132 0088
US: +1 650 419 9974
Europe: +45 4586 9000
Japan: +81 03 5403 6975

contact@chempartner.com